Elite in Pyoderma Gangrenosum

Dr. Emanual M. Maverakis

Dermatology
Regents Of The Univ Of Ca
2315 Stockton Blvd, 
Sacramento, CA 
Offers Telehealth
Elite in Pyoderma Gangrenosum
Regents Of The Univ Of Ca
2315 Stockton Blvd, 
Sacramento, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Emanual Maverakis is a Dermatologist in Sacramento, California. Dr. Maverakis is rated as an Elite provider by MediFind in the treatment of Pyoderma Gangrenosum. His top areas of expertise are Pyoderma Gangrenosum, Pemphigus, Pemphigus Vulgaris, and Psoriasis.

His clinical research consists of co-authoring 213 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 15 articles in the study of Pyoderma Gangrenosum.

Specialties
Dermatology
Licenses
Dermatology in CA
Hospital Affiliations
University Of California Davis Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
Sutter Health
  • HMO
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Health Advantage
  • HMO
  • INSURANCE PLAN
  • MEDICARE DISCOUNT CARD
  • MEDICARE MAPD
View 11 Less Insurance Carriers -

Locations

REGENTS OF THE UNIV OF CA
2315 Stockton Blvd, Sacramento, CA 95817
Other Locations
REGENTS OF THE UNIV OF CA
3301 C St, Suite 800b, Sacramento, CA 95816

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 2/Phase 3
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
Enrollment Status: Completed
Publish Date: May 14, 2025
Comparing Immune Responses to Topical Imiquimod
Comparing Immune Responses to Topical Imiquimod
Enrollment Status: Terminated
Publish Date: November 07, 2024
Intervention Type: Drug
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: September 27, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Parallel-group, Randomized, Placebo-controlled Ascending Dose Phase I Study Protocol for Dietary Supplementation With Bifidobacterium Longum Subsp. Infantis (B. Infantis) in Healthy Breastfed Infants
A Parallel-group, Randomized, Placebo-controlled Ascending Dose Phase I Study Protocol for Dietary Supplementation With Bifidobacterium Longum Subsp. Infantis (B. Infantis) in Healthy Breastfed Infants
Enrollment Status: Withdrawn
Publish Date: November 15, 2019
Intervention Type: Drug
Study Phase: Phase 1
A Randomized Placebo Controlled Split-body Double-blind Phase II Clinical Trial to Investigate the Safety and Efficacy of Clobetasol 0.05% Ointment for the Treatment of Toxic Epidermal Necrolysis (TEN)
A Randomized Placebo Controlled Split-body Double-blind Phase II Clinical Trial to Investigate the Safety and Efficacy of Clobetasol 0.05% Ointment for the Treatment of Toxic Epidermal Necrolysis (TEN)
Enrollment Status: Withdrawn
Publish Date: August 09, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 7 Less Clinical Trials

213 Total Publications

Defining On-Treatment Remission in Plaque Psoriasis: A Consensus Statement From the National Psoriasis Foundation.
Defining On-Treatment Remission in Plaque Psoriasis: A Consensus Statement From the National Psoriasis Foundation.
Journal: JAMA dermatology
Published: June 18, 2025
Similar Doctors
Elite in Pyoderma Gangrenosum
Dr. Alain Brassard
Dermatology
Elite in Pyoderma Gangrenosum
Dr. Alain Brassard
Dermatology

Regents Of The Univ Of Ca

2315 Stockton Blvd, 
Sacramento, CA 
 (0.1 miles away)
916-734-2011
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Alain Brassard is a Dermatologist in Sacramento, California. Dr. Brassard is rated as a Distinguished provider by MediFind in the treatment of Pyoderma Gangrenosum. His top areas of expertise are Pyoderma Gangrenosum, Hidradenitis Suppurativa, Actinic Keratosis, Psoriasis, and Liver Embolization.

Atrin M. Toussi
Distinguished in Pyoderma Gangrenosum
Dr. Atrin M. Toussi
Dermatology
Distinguished in Pyoderma Gangrenosum
Dr. Atrin M. Toussi
Dermatology

West Roseville Care Center

2050 Blue Oaks Boulevard, 
Roseville, CA 
 (17.2 miles away)
916-910-2470
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Atrin Toussi is a Dermatologist in Roseville, California. Dr. Toussi is rated as an Advanced provider by MediFind in the treatment of Pyoderma Gangrenosum. Her top areas of expertise are Pyoderma Gangrenosum, Psoriasis, Porphyria Cutanea Tarda, and Livedo Reticularis. Dr. Toussi is currently accepting new patients.

Distinguished in Pyoderma Gangrenosum
Dr. Jonathan W. Rick
Dermatology
Distinguished in Pyoderma Gangrenosum
Dr. Jonathan W. Rick
Dermatology

Regents Of The Univ Of Ca

3301 C St, Suite 800b, 
Sacramento, CA 
 (1.8 miles away)
916-703-3300
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jonathan Rick is a Dermatologist in Sacramento, California. Dr. Rick is rated as an Advanced provider by MediFind in the treatment of Pyoderma Gangrenosum. His top areas of expertise are Calciphylaxis, Pyoderma Gangrenosum, Hidradenitis Suppurativa, Traumatic Brain Injury, and Craniectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Maverakis's expertise for a condition
ConditionClose
View All 19 Advanced Conditions
View All 170 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile